NIP7P1

Across TCGA pan-cancer cohorts, NIP7P1 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated NIP7P1 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher NIP7P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NIP7P1 expression acts as an unfavorable survival marker.

LIHC, CESC, and LGG are the cancer types where NIP7P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	III,IV	0.094	0.424	.003	27	view →
CESC	OS	Tertile	III,IV	0.167	0.657	.044	18	view →
LGG	DFS	Tertile	All	0.414	0.765	.017	15	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

NIP7P1–LIHC (DFS)

Open the LIHC breakdown →